Autologous natural killer cells and lymphodepleting chemotherapy for the treatment of cancer

Details for Australian Patent Application No. 2007223093 (hide)

Owner Government of The United States of America, Represented by the Secretary, Department of Health and Human Services

Inventors Rosenberg, Steven A.; Parkhurst, Maria R.

Agent Fisher Adams Kelly

Pub. Number AU-A-2007223093

PCT Pub. Number WO2007/103901

Priority 60/779,863 06.03.06 US

Filing date 6 March 2007

Wipo publication date 13 September 2007

International Classifications

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

A61K 35/14 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Blood

Event Publications

25 September 2008 PCT application entered the National Phase

  PCT publication WO2007/103901 Priority application(s): WO2007/103901

4 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007223102-Specific amplification of fetal DNA sequences from a mixed, fetal-maternal source

2007223086-Aldolases, nucleic acids encoding them and methods for making and using them